Placebo
Showing 51 - 75 of >10,000
Alcohol Use Disorder Trial (Regular Human Insulin then Placebo, Placebo then Regular Human Insulin)
Not yet recruiting
- Alcohol Use Disorder
- Regular Human Insulin then Placebo
- Placebo then Regular Human Insulin
- (no location specified)
Aug 9, 2023
Hyposmia Trial (CYR-064)
Not yet recruiting
- Hyposmia
- CYR-064
- (no location specified)
Aug 24, 2023
Brain Injuries, Traumatic Trial (Cannabidiol, Placebo)
Not yet recruiting
- Brain Injuries, Traumatic
- Cannabidiol
- Placebo
- (no location specified)
Jan 25, 2023
Atopic Dermatitis Trial in Shanghai (0.1% QY211 Gel or , 0.3% QY211 Gel or , 0.8% QY211 Gel or )
Recruiting
- Atopic Dermatitis
- 0.1% QY211 Gel or placebo
- +3 more
-
Shanghai, Shanghai, ChinaHuashan Hospital Affiliated to Fudan University
Apr 24, 2023
Adenocarcinoma of Stomach Trial in Shanghai (Gentuximab Injection, Gentuximab Injection Placebo)
Recruiting
- Adenocarcinoma of Stomach
- Gentuximab Injection
- Gentuximab Injection Placebo
-
Shanghai, Shanghai, ChinaShanghai Dongfang Hospital
Jun 16, 2023
IgA Nephropathy, Immunoglobulin A Nephropathy Trial (Atrasentan, Placebo)
Not yet recruiting
- IgA Nephropathy
- Immunoglobulin A Nephropathy
- Atrasentan
- Placebo
- (no location specified)
Apr 27, 2023
Endometriosis, Moderate to Severe Endometriosis-associated Pain Trial (BG2109 100mg, BG2109 200mg, ABT(E2 1 mg / NETA 0.5 mg))
Not yet recruiting
- Endometriosis
- Moderate to Severe Endometriosis-associated Pain
- BG2109 100mg
- +5 more
- (no location specified)
Jun 6, 2023
Allergic Rhinitis Due to Weed Pollen, Allergic Rhinitis Trial in Melbourne (INI-2004, Placebo)
Recruiting
- Allergic Rhinitis Due to Weed Pollen
- Allergic Rhinitis
- INI-2004
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Sep 7, 2023
Psychiatric Disorders, Insomnia Trial in Copenhagen NV (Melatonin, Quetiapine, Placebo)
Recruiting
- Psychiatric Disorders
- Insomnia
- Melatonin
- +2 more
-
Copenhagen NV, DenmarkMental Health Center Copenhagen
Sep 25, 2023
Neuropathic Pain, Diabetic Neuropathies, Post Herpetic Neuralgia Trial in Seoul (AJH-2947 100 mg (SAD), Placebo, AJH-2947 200 mg
Recruiting
- Neuropathic Pain
- +2 more
- AJH-2947 100 mg (SAD)
- +9 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Nov 22, 2023
Migraine Trial (Zavegepant 10 mg, Placebo - Control 1, Placebo - Control 2)
Not yet recruiting
- Migraine
- Zavegepant 10 mg
- +2 more
- (no location specified)
Oct 22, 2023
Ulcerative Colitis Trial (IV MK-7240, IV Placebo, SC MK-7240)
Not yet recruiting
- Ulcerative Colitis
- IV MK-7240
- +3 more
- (no location specified)
Sep 27, 2023
Long COVID Trial in Milan (VSL#3®, Placebo)
Recruiting
- Long COVID
- VSL#3®
- Placebo
-
Milan, MI, ItalyFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
May 22, 2023
Recurrent Urinary Tract Infection Trial (Probiotic, Probiotic + , Placebo)
Not yet recruiting
- Recurrent Urinary Tract Infection
- Probiotic
- +2 more
- (no location specified)
May 31, 2023
Food Allergy Trial (Drug: Chinese Herbal Medication, Drug: Placebo, Drug: Omalizumab)
Completed
- Food Allergy
- Drug: Chinese Herbal Medication
- +2 more
- (no location specified)
Oct 24, 2023
Photodamaged Skin Trial (Vitamin C with AHA Exfoliative Serum, Placebo serum)
Not yet recruiting
- Photodamaged Skin
- Vitamin C with AHA Exfoliative Serum
- Placebo serum
- (no location specified)
Jun 19, 2023
Obstructive Sleep Apnea Trial (IHL-42X Low Dose, IHL-42X High Dose, Placebo)
Not yet recruiting
- Obstructive Sleep Apnea
- IHL-42X Low Dose
- +5 more
- (no location specified)
Nov 22, 2023